Results 161 to 170 of about 9,989 (175)

Investigation of formulation factors affecting in vitro and in vivo characteristics of a galantamine transdermal system

International Journal of Pharmaceutics, 2012
Chun-Woong Park, Ju-Young Kim, Tack-Oon Oh   +2 more
exaly  

Galantamine hydrobromide: An agent for Alzheimer’s disease

American Journal of Health-System Pharmacy, 2003
Sramek John J, Cutler Neal R
exaly  

Galantamine

Reactions Weekly, 2005
openaire   +1 more source

Galantamine

Reactions Weekly
openaire   +2 more sources

Galantamine Extended Release

CNS Drugs, 2012
Dean M Robinson, Greg L Plosker, Robinson Dean M   +2 more
exaly  

Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease

International Journal of Geriatric Psychiatry, 2001
exaly  

Galantamine elicits neuroprotection by inhibiting iNOS, NADPH oxidase and ROS in hippocampal slices stressed with anoxia/reoxygenation

Neuropharmacology, 2012
Javier Egea, Maria Dolores Martín-De-Saavedra, Alejandro Romero   +2 more
exaly  

Antioxidative properties of galantamine on neuronal damage induced by hydrogen peroxide in SK–N–SH cells

NeuroToxicology, 2008
France Massicot
exaly  

Effects of Statins on Cognitive Function in Patients with Alzheimer???s Disease in Galantamine Clinical Trials

Drugs and Aging, 2012
Bengt Winblad, Vesna Jelic, Paul Kershaw   +2 more
exaly  

Galantamine

Reactions Weekly, 2014
openaire   +1 more source